Alloy Therapeutics has appointed Venkat Krishnamurthy as chief scientific officer of its genetic medicines division. Krishnamurthy previously served as CSO at Flashpoint Therapeutics, bringing extensive leadership experience in the genetic medicine space. The hiring reflects Alloy’s strategic expansion of its pipeline and commitment to innovative therapeutic development.
Krishnamurthy’s diverse background underscores the importance of balancing rigorous scientific work with personal pursuits, a philosophy he believes keeps a scientist both sharp and inspired.
Also Read
- AMA Enters the Fray to Combat Medical Misinformation
- STAT+: PepGen says early trial for muscular dystrophy drug looks promising
- When a Gun Owner Shows Early Signs of Dementia
- Japanese Man’s Severe Head Tremor and Cognitive Decline Linked to Rare Aqueductal Web, Resolved by Ventriculoperitoneal Shunt